Company Filing History:
Years Active: 2008-2011
Title: Ruchika Gupta: Innovator in Cancer Research
Introduction
Ruchika Gupta is a prominent inventor based in San Diego, CA, known for her significant contributions to cancer research. She has been awarded three patents, showcasing her innovative work in the field of cell migration and its implications in breast cancer progression.
Latest Patents
One of her latest patents focuses on "Compositions and methods for inhibiting cell migration." This research highlights the dual function of Dickkopf1 (Dkk1) as a protein that coordinates cell migration while antagonizing Wnt/β-catenin signaling during both developmental and pathological processes. The study reveals that the expression profile of Dkk proteins in human breast cancers correlates with various indicators of patient outcomes. Specifically, Dkk1 is associated with markers of poor prognosis, while the expression of single-function Dkk2 or Dkk3 correlates with better prognostic phenotypes. The findings suggest that the pro-migratory activities of Dkk1 and Dkk3 provide new insights into breast cancer progression and open potential avenues for therapeutic intervention.
Career Highlights
Ruchika Gupta is affiliated with the Burnham Institute, where she continues her groundbreaking research. Her work has garnered attention for its potential impact on understanding and treating breast cancer.
Collaborations
Ruchika collaborates with Mark Mercola, further enhancing the research efforts at the Burnham Institute.
Conclusion
Ruchika Gupta's innovative research and patents contribute significantly to the understanding of cancer biology, particularly in breast cancer progression. Her work not only advances scientific knowledge but also holds promise for future therapeutic strategies.